Skip to main content
Premium Trial:

Request an Annual Quote

Funding Update: NSF Bioinformatics Grants Awarded Oct 23 — Nov 19, 2013

Premium

Modeling Protein Degradation — Evaluation of Strategies and Targets
Start Date: Nov. 15, 2013
Expires: Oct. 31, 2015
Awarded Amount to Date: $300,000
Principal Investigators: Christine Vogel, Dennis Shasha
Sponsor: New York University

According to the abstract, the funds will support the use of mass spectrometry and bioinformatics to combine proteomic data such as protein ubiquitination status and degradation, with information on protein sequence and structure to discover features that impact protein stability.


Development and Application of Multi-scale Modeling for Biomolecular Association
Start Date: May 1, 2014
Expires: April 30, 2019
Awarded Amount to Date: $351,038
Principal Investigators: Chia-en Chang
Sponsor: University of California, Riverside

According to the abstract, the investigators will combine "multi-level coarse-grained and atomistic simulations to efficiently and accurately model molecular associations and kinetic enhancement of the enzymes and nanoparticle systems." The methods developed as part of this project are expected to "improve understanding of protein-ligand binding kinetics and assist the design of nanostructures, nanoparticles, and engineered enzymes."


Filed under

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.